Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gastrointestinal stromal tumors: report of an audit and review of the literature.
Biasco G, Velo D, Angriman I, Astorino M, Baldan A, Baseggio M, Basso U, Battaglia G, Bertin M, Bertorelle R, Bocus P, Brosolo P, Bulzacchi A, Cannizzaro R, Da Dalt GF, Di Battista M, Errante D, Fedrigo M, Frustaci S, Lionetti I, Massani M, Mencarelli R, Montesco MC, Norberto L, Pantaleo MA, Pasquali C, Pastorelli D, Rossi CR, Ruffolo C, Salvagno L, Saponara MS, Vittadello F, Zaccaria F, Zovato S, Farinati F; Section of Oncology of the Italian Society of Gastroenterology; Interdisciplinary GIST Group-G.I.GIST, Veneto Institute of Oncology IOV-IRCCS Azienda Ospedale, University of Padua; GIST Study Group, Bologna University. Biasco G, et al. Among authors: frustaci s. Eur J Cancer Prev. 2009 Apr;18(2):106-16. doi: 10.1097/CEJ.0b013e32830c8da8. Eur J Cancer Prev. 2009. PMID: 19337057 Review.
Combined modality treatment for locally advanced gastric cancer.
De Paoli A, Buonadonna A, Boz G, Lombardi D, Innocente R, Tumolo S, Tosolini G, Rossi C, Trovò MG, Frustaci S. De Paoli A, et al. Among authors: frustaci s. Suppl Tumori. 2003 Sep-Oct;2(5):S58-62. Suppl Tumori. 2003. PMID: 12914394
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma.
Bajetta E, Di Bartolomeo M, Mariani L, Cassata A, Artale S, Frustaci S, Pinotti G, Bonetti A, Carreca I, Biasco G, Bonaglia L, Marini G, Iannelli A, Cortinovis D, Ferrario E, Beretta E, Lambiase A, Buzzoni R; Italian Trials in Medical Oncology (I.T.M.O.) Group. Bajetta E, et al. Among authors: frustaci s. Cancer. 2004 Jan 15;100(2):279-87. doi: 10.1002/cncr.11910. Cancer. 2004. PMID: 14716761 Free article. Clinical Trial.
Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC).
Berretta M, Zanet E, Nasti G, Lleshi A, Frustaci S, Fiorica F, Bearz A, Talamini R, Lestuzzi C, Lazzarini R, Fisichella R, Cannizzaro R, Iaffaioli RV, Berretta S, Tirelli U. Berretta M, et al. Among authors: frustaci s. Arch Gerontol Geriatr. 2012 Sep-Oct;55(2):271-5. doi: 10.1016/j.archger.2011.08.016. Epub 2011 Sep 19. Arch Gerontol Geriatr. 2012. PMID: 21937127
Lymphangioleiomyomatosis: a case report and review of the literature.
Bearz A, Rupolo M, Canzonieri V, Balestreri L, La Mura N, Berretta M, Colussi AM, Frustaci S. Bearz A, et al. Among authors: frustaci s. Tumori. 2004 Sep-Oct;90(5):528-31. doi: 10.1177/030089160409000519. Tumori. 2004. PMID: 15656345 Review.
Prognostic factors in soft tissue sarcomas: a study of 395 patients.
Stefanovski PD, Bidoli E, De Paoli A, Buonadonna A, Boz G, Libra M, Morassut S, Rossi C, Carbone A, Frustaci S. Stefanovski PD, et al. Among authors: frustaci s. Eur J Surg Oncol. 2002 Mar;28(2):153-64. doi: 10.1053/ejso.2001.1242. Eur J Surg Oncol. 2002. PMID: 11884051
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.
Grignani G, Palmerini E, Stacchiotti S, Boglione A, Ferraresi V, Frustaci S, Comandone A, Casali PG, Ferrari S, Aglietta M. Grignani G, et al. Among authors: frustaci s. Cancer. 2011 Feb 15;117(4):826-31. doi: 10.1002/cncr.25632. Epub 2010 Oct 5. Cancer. 2011. PMID: 20925044 Free article. Clinical Trial.
The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.
Toffoli G, Cecchin E, Corona G, Russo A, Buonadonna A, D'Andrea M, Pasetto LM, Pessa S, Errante D, De Pangher V, Giusto M, Medici M, Gaion F, Sandri P, Galligioni E, Bonura S, Boccalon M, Biason P, Frustaci S. Toffoli G, et al. Among authors: frustaci s. J Clin Oncol. 2006 Jul 1;24(19):3061-8. doi: 10.1200/JCO.2005.05.5400. J Clin Oncol. 2006. PMID: 16809730 Clinical Trial.
Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy.
Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, Martin J, Comandone A, Cruz J, Ferraro A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Casali PG, Gronchi A. Stacchiotti S, et al. Among authors: frustaci s. Cancer. 2012 Dec 1;118(23):5857-66. doi: 10.1002/cncr.27624. Epub 2012 May 17. Cancer. 2012. PMID: 22605504 Free article.
83 results